FEDERATED HERMES, INC.

Position in PLRX — Pliant Therapeutics, Inc.

CIK 1056288 PITTSBURGH, PA

Position in PLRX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$78,940

+$6,357 QoQ

Shares Held

62,651

+5.3% QoQ

Ownership

0.101%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FEDERATED HERMES, INC. holds $2,358,506,481 across 147 Biotechnology names. PLRX ranks #94 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	687,816	$227,577,679
2	REGN	Regeneron Pharmaceuticals, Inc.	254,946	$196,981,475
3	RYTM	Rhythm Pharmaceuticals, Inc.	1,286,303	$111,869,771
4	MRNA	Moderna, Inc.	1,977,079	$100,435,613
5	IDYA	IDEAYA Biosciences, Inc.	2,987,107	$99,530,405
6	INSM	INSMED Inc	538,257	$88,015,784
7	CNTA	Centessa Pharmaceuticals plc	2,049,439	$81,403,717
8	EYPT	EyePoint, Inc.	5,669,589	$73,081,000

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$78,940	62,651	+5.3%	Shares	Defined	2026-05-11
2025-12-31	$72,583	59,495	+7.6%	Shares	Defined	2026-02-12
2025-09-30	$81,838	55,296	-35.3%	Shares	Defined	2025-11-03
2025-06-30	$99,088	85,421	+44.3%	Shares	Defined	2025-08-13
2025-03-31	$79,932	59,209	+1557.6%	Shares	Defined	2025-05-08
2024-12-31	$47,043	3,572	+61.7%	Shares	Defined	2025-02-13
2024-09-30	$24,762	2,209	-97.2%	Shares	Defined	2024-11-13
2023-03-31	$2,120,871	79,732	0.0%	Shares	Defined	2023-05-08
2022-12-31	$1,541,219	79,732	0.0%	Shares	Defined	2023-02-13
2022-09-30	$1,665,601	79,732	-75.9%	Shares	Defined	2022-11-14
2022-06-30	$2,655,274	331,495	+25.0%	Shares	Defined	2022-09-16
2022-03-31	$1,858,855	265,172	+624.2%	Shares	Defined	2022-05-13
2021-12-31	$494,343	36,618	—	Shares	Defined	2022-02-14
No filing history on record for this holder in this stock.